Genomics Market Size, Growth, Demands Outlook and Forecasts to 2030

According to the research report, the global genomics market size is expected to touch USD 98.7 Billion by 2030, from USD 24.3 Billion in 2021, growing with a significant CAGR of 16.85% from 2022 to 2030.

Genomics Market Size 2022 to 2030

The genomics market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global genomics market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global genomics market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global genomics market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1204

Market Scope

Report Highlights	Details
Market Size	USD 98.7 Billion by 2030
Growth Rate	CAGR of 16.85% From 2022 to 2030
Base Year	2020
Historic Data	2017 to 2020
Forecast Period	2022 to 2030
Segments Covered	Product and Services, Technology, Application, End-Users
Regional Scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

This study covers a detailed segmentation of the global genomics market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global genomics market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

Thermo Fisher Scientific, Inc.
Illumina, Inc.
Oxford Nanopore Technologies
QIAGEN N.V.
BGI
Eurofins Scientific
GE Healthcare
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Hoffmann-La Roche Ltd.
Others

Market Segmentation

By Product and Services

Consumables
Systems and software
Services Equipment

By Technology

PCR (polymerase chain reaction)
Sequencing
Microarray
Nucleic acid extraction and purification
Other technologies (branched DNA analysis, single-cell genomics analysis, and flow cytometry)

By Application

Drug discovery and development
Diagnostics
Precision medicine
Agriculture and animal research
Other applications

By End-Users

Hospitals & clinics
Research centers and academic & government institutes
Pharmaceutical & biotechnology companies
Other end users

By Regional Outlook

North America
- US.
- Canada
Europe
- UK.
- Germany
- France
Asia Pacific
- China
- India
- Japan
- Southeast Asia
Middle East and Africa
- GCC
- North Africa
- South Africa
- Rest of MEA

Research Methodology

The research methodology adopted by analysts for compiling the global genomics market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global genomics market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Genomics Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Genomics Market

5.1. Covid-19: Genomics Industry Impact
5.2. Genomics Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Genomics Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Genomics Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Genomics Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Driver 1
6.1.1.2. Driver 2
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2

Chapter 7. Global Genomics Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Genomics Market Revenue by Market Players (2017-2021)
7.1.1.2. Genomics Market Revenue Market Share by Market Players (2017-2021)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product Type Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Genomics Market, By Product Type

8.1. Genomics Market, by Component, 2018-2030
8.1.1. Consumables
8.1.1.1. Market Revenue and Forecast (2018-2030)
8.1.2. Systems and software
8.1.2.1. Market Revenue and Forecast (2018-2030)
8.1.3. Services Equipment
8.1.3.1. Market Revenue and Forecast (2018-2030)

Chapter 9. Global Genomics Market, By Application

9.1. Genomics Market, by Application, 2018-2030
9.1.1. Sequencing
9.1.1.1. Market Revenue and Forecast (2018-2030)
9.1.2. Microarray
9.1.2.1. Market Revenue and Forecast (2018-2030)
9.1.3. PCR (polymerase chain reaction)
9.1.3.1. Market Revenue and Forecast (2018-2030)
9.1.4. Nucleic acid extraction and purification
9.1.4.1. Market Revenue and Forecast (2018-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2018-2030)

Chapter 10. Global Genomics Market, By End-user

10.1. Genomics Market, by End-user, 2018-2030
10.1.1. Diagnostics
10.1.1.1. Market Revenue and Forecast (2018-2030)
10.1.2. Drug discovery and development
10.1.2.1. Market Revenue and Forecast (2018-2030)
10.1.3. Precision medicine
10.1.3.1. Market Revenue and Forecast (2018-2030)
10.1.4. Agriculture and animal research
10.1.5. Other applications

Chapter 11. Global GenomicsMarket, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product Type(2018-2030)
11.1.2. Market Revenue Forecast by Application (2018-2030)
11.1.3. Market Revenue Forecast by End-user (2018-2030)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2018-2030)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2018-2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Product Type(2018-2030)
11.2.2. Market Revenue Forecast by Application (2018-2030)
11.2.3. Market Revenue Forecast by End-user (2018-2030)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2018-2030)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2018-2030)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2018-2030)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2018-2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product Type(2018-2030)
11.3.2. Market Revenue Forecast by Application (2018-2030)
11.3.3. Market Revenue Forecast by End-user (2018-2030)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2018-2030)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2018-2030)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2018-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2018-2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product Type(2018-2030)
11.4.2. Market Revenue Forecast by Application (2018-2030)
11.4.3. Market Revenue Forecast by End-user (2018-2030)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2018-2030)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2018-2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product Type(2018-2030)
11.5.2. Market Revenue Forecast by Application (2018-2030)
11.5.3. Market Revenue Forecast by End-user (2018-2030)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2018-2030)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2018-2030)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2018-2030)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2018-2030)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin (2017-2021)
12.1.4. Recent Developments and Strategies
12.2. Illumina, Inc.
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin (2017-2021)
12.2.4. Recent Developments and Strategies
12.3. Oxford Nanopore Technologies
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin (2017-2021)
12.3.4. Recent Developments and Strategies
12.4. QIAGEN N.V.
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin (2017-2021)
12.4.4. Recent Developments and Strategies
12.5. BGI
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin (2017-2021)
12.5.4. Recent Developments and Strategies
12.6. Eurofins Scientific
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin (2017-2021)
12.6.4. Recent Developments and Strategies
12.7. GE Healthcare
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin (2017-2021)
12.7.4. Recent Developments and Strategies
12.8. Agilent Technologies, Inc.
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin (2017-2021)
12.8.4. Recent Developments and Strategies
12.9. Bio-Rad Laboratories, Inc.
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin (2017-2021)
12.9.4. Recent Developments and Strategies
12.10. F. Hoffmann-La Roche Ltd.
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin (2017-2021)
12.10.4. Recent Developments and Strategies